amoxapine has been researched along with Brain Vascular Disorders in 1 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shima, S | 1 |
1 trial available for amoxapine and Brain Vascular Disorders
| Article | Year |
|---|---|
The efficacy of antidepressants in post-stroke depression.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Amoxapine; Antidepressive Agents, Tricyclic; Cerebrov | 1997 |